Dr. Geraldine Walsh
The Centre for Innovation’s annual progress report details the achievements made over the past year by Canadian Blood Services’ network of scientists, medical experts, research partners, and collaborators.
By ensuring that innovation respects the rights of research participants, the Research Ethics Board helps Canadian Blood Services advance high quality health research to improve the lives of Canadians.
The Canadian Society for Transfusion Medicine’s annual conference took place in Calgary, Alberta in early June. The Centre for Innovation’s Geraldine Walsh was there and shares her highlights.
Before launching the Canadian Blood Services’ Lay Science Writing Competition for research trainees, the Centre for Innovation made sure to have the right team in place. Valuable support from Science Borealis and the Centre for Blood Research helped make our inaugural competition a success.
Dr. Jason Acker was recently awarded the University of Alberta Graduate Students’ Association (GSA) Graduate Student Supervisor Award. We chatted to Dr. Acker to find out what this award means to him.
In the delicate balance between clotting and bleeding, current laboratory research being undertaken by our partners is evolving our knowledge of how anticoagulant drugs work
The results of our first-ever Lay Science Writing Competition are in, read-on to discover who gets top-prize and what happens next.
We just published our 50th Research Unit. Read on to discover how you can use this trove of information to learn more about the excellent work conducted at the Canadian Blood Services Centre for Innovation.
This primer is part I of our new series exploring the future of blood banking. Given that D is also for Development: Canadian Blood Services and the Centre for Innovation have been following the development of pathogen inactivation technologies and how they can be used to improve safety. Read-on to learn more about these technologies and their potential to shift the blood safety paradigm.
This month’s Research Unit describes efforts by researchers to create a simulation and modelling study to understand how the risk of transfusion-transmission of HTLV would change if the screening were modified.